SCHEMBL19648323

SCHEMBL19648323

CC(=O)Nc1cc([N+](=O)[O-])cnc1C=N

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.51
GAA P10253 1/20 0.51
SMN1; SMN2 Q16637 3/20 0.43
CYP19A1 P11511 1/20 0.41
LMNA P02545 3/20 0.39
NPSR1 Q6W5P4 2/20 0.39
POLB P06746 2/20 0.39
ALDH1A1 P00352 2/20 0.39
GALR2 O43603 1/20 0.39
MITF O75030 1/20 0.39
HSP90AA1 P07900 1/20 0.39
HPGD P15428 1/20 0.39
XBP1 P17861 1/20 0.39
CCR6 P51684 1/20 0.39
MAPT P10636 4/20 0.39
KMT2A Q03164 3/20 0.39
DYRK1A Q13627 2/20 0.39
MEN1 O00255 2/20 0.39
CSNK2A2 P19784 1/20 0.37
CSNK2B P67870 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16680219 0.75 CYP1A2 (0.52) CYP1A2GAASMN1; SMN2CYP19A1LMNA
SCHEMBL944219 0.72 CYP1A2 (0.63) CYP1A2GAASMN1; SMN2LMNAPOLB
SCHEMBL914646 0.71 GAA (0.54) CYP1A2GAASMN1; SMN2CYP19A1ALDH1A1
SCHEMBL11637319 0.69 SMN1; SMN2 (0.57) CYP1A2GAASMN1; SMN2CYP19A1NPSR1
SCHEMBL4326710 0.68 SMN1; SMN2 (0.58) CYP1A2GAASMN1; SMN2CYP19A1ALDH1A1
SCHEMBL4727523 0.68 GAA (0.46) CYP1A2GAASMN1; SMN2LMNAPOLB
SCHEMBL915213 0.68 MEN1 (0.64) GAASMN1; SMN2LMNAPOLBALDH1A1
SCHEMBL474857 0.68 CYP1A2 (1.00) CYP1A2GAASMN1; SMN2LMNAALDH1A1
SCHEMBL9445618 0.68 SMN1; SMN2 (0.51) CYP1A2GAASMN1; SMN2CYP19A1LMNA
SCHEMBL18534510 0.68 MEN1 (0.54) CYP1A2GAASMN1; SMN2POLBALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2846804-B1 TETRAHYDRONAPHTHYRIDINE AND RELATED BICYCLIC COMPOUNDS FOR INHIBITION OF RORgamma ACTIVITY AND THE TREATMENT OF DISEASE MERCK SHARP & DOHME (US) 2017-11-29 EP disclosed